Gains in childhood cancer survival slow

02/19/2013 | Bloomberg Businessweek

Although the five-year survival rate of children with cancer increased from 30% in the 1960s to 80% in the 2000s, improvement has leveled off, physicians wrote in Lancet Oncology. The report's authors say the approach to research and regulation must be modernized to address the issue. Just 15 childhood cancer drugs have been allowed for use in children since 1998.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ